Login / Signup

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML.

Claire M LucasLaura J ScottNatasha CarmellAlison K HolcroftRobert K HillsAlan K BurnettRichard E Clark
Published in: Blood advances (2019)
Keyphrases
  • acute myeloid leukemia
  • signaling pathway
  • cell proliferation
  • protein kinase
  • allogeneic hematopoietic stem cell transplantation